Prevention of Coronary Artery Disease in Diabetic Patients

Wingard Dl , Barrett-Connor E Diabetes in America. 2nd ed. Harris Mi , ed. Washington, DC: U.S. Government Printing Office; 1995:429-448.

Sowers Jr , Epstein M .Diabetes Mellitus and associated hypertension, vascular disease, and nephropathy, an update.Hypertension. 26:869-879

Brownlee M .Glycation products and the pathogenesis of diabetic complications.Diabetes Care. 15:1835-1843

Bucala R , Makita Z , Koschinsky T , Cerami A .Lipid advanced glycosylation: pathway for lipid oxidation in vivo.Proc Natl Acad Sci USA. 91:9441-9445

Steinberg D , Parthasathy S , Carew Te , Khou Jc , Witzum Jl .Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenecity.N Engl J Med. 1989;320:913-924

A study of the effects of hypoglycemie agents on vascular complications in patients with adult-onset diabetes II. Mortality Results.Diabetes. 1976;19 (Suppl. 2): 785-930

Haffner S .Management of Dyslipidemia in Adults with Diabetes.Diabetes Care. 1998;21:160-178

Haffner S , Stern Mp , Hazuda Hp , Mitchell Bd , Patterson Jk .Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes?.JAMA. 1990;263:2893-2898

Haffner Sm , Lehto S , Ronnemaa T , Pyorala K , Laakso M. .Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.NEJM. 1998;339:229-234

Management of dyslipidemia in adults with diabetes.Diabetes Care. 1998;21:179-182

Sowers Jr , Epstein M .Diabetes Mellitus and associated hypertension, vascular disease, and nephropathy, an update.Hypertension. 1995;26:869-879

Fournier Am , Gadia Mt , Kubrusly Db .Blood pressure, insulin, and glycemia in nondiabetic subjects.Am J Med. 1986;80:861-864

Skyler Js , Marks Jb , Schneiderman N .Hypertension in Patients with Diabetes Mellitus.Am J Hypertens. 1995;8:100S-105S

Hall Je , Coleman Tg , Mizelle Hl .Does chronic hyperinsulinemia cause hypertension?.Am J Hypertens. 1989;2:171-173

Lewis Ej , Hunsicker Lg , Bain Rp .The effect of angiotensin-converting enzyme therapy on diabetic nephropathy.N Engl J Med. 1993;329:1456-1462

Ravid M , Savin H , Jutrin I .Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.Ann Int Med. 1993;118:577-581

Mordchai R , Brosh D , Levi Z .Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus.Ann Int Med. 1998;128:982-988

Estacio Ro , Jeffers Bw , Hiatt Wr , Biggi Sl , Gifford N , Schrier Rw. .The effect of nisoldipine as compared with enalapril on cardiovascular events in patients with non-insulindependent diabetes and hypertension.N Eng J Med. 1998;338:645-652

Tattti P , Pahor M , Byington Rp , Dimauro P , Guarisco R , Strollo F. .Results of the Fosinopril Amlodipine Cardiovascular Events Trial (FACET) in hypertensive patients with noninsulin dependent diabetes mellitus (NIDDM).Circulation. 1997;96 (Suppl I): 1-764

Mordchai R , Brosh D , Levi Z , Bar-Dayan Y , Ravid D , Rachmani R .Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus.Ann IntMed. 1988;128:982-988

Lehtonen A .Lowered levels of serum insulin, glucose and cholesterol in hypertensive patients during treatment with doxazocin.Cur Ther Res. 1990;47:278-284

Warram Jh , Laffel Lmb , Vasania P , Christlieb Ar , Krolewski As. .Excess mortality associated with diuretic therapy in diabetes mellitus.Arch Int Med. 1991;151:1350-1356

Halushka Pv , Rogers Rc , Loadholdt Cb , Colwell Ja. .Increased platelet thrombaoxane synthesis in diabetes mellitus.J Lab Clin Med. 1981;97:87-96

Davi G , Catalano I , Averna M. .Thromboxane biosynthesis and platelet function in type II diabetes mellitus.N Eng J Med. 1990;322:1769-1774

Colwell J. .Aspirin therapy in diabetes.Diabetes Care. 1997;20:1767-1771

Final report on the aspirin component of the ongoing Physicians' Health Study.N Eng J Med. 1989;321:129-135

Collaborative overview of randomized trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.BMJ. 1994;308:71-72

Aspirin Therapy in Diabetes.Diabetes Care. 1997;20:1772-1773

29.HERS Study Group.Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: The Heart and Estrogen/progestin Replacement Study (HERS). JAMA.

Kaplan Rc , Heckbert Sr .Postmenopausal estrogen and risk of myocardial infarction in diabetic women.Diabetes Care. 1998;21:1117-1121

31.News Release, American Diabetes Association, June 16, 1998.

Consensus development conference on the diagnosis of coronary heart disease in people with diabetes.Diabetes Care. 1998;21:1551-1559